Prosecution Insights
Last updated: April 19, 2026

Examiner: PIPIC, ALMA

Tech Center 1600 • Art Units: 1617

This examiner grants 55% of resolved cases

Performance Statistics

54.6%
Allow Rate
-5.4% vs TC avg
753
Total Applications
+56.9%
Interview Lift
1149
Avg Prosecution Days
Based on 696 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
10.2%
§102 Novelty
40.6%
§103 Obviousness
32.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19330192 COMBINATION REMEDY Non-Final OA SYMRISE AG
17423400 COMBINATION REMEDY Final Rejection SYMRISE AG
17785170 THICKENER Final Rejection KANEKA CORPORATION
18306872 NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS Non-Final OA The Johns Hopkins University
17962515 PROCESS FOR ALTERING THE COLOR OF KERATIN FIBERS Final Rejection L'Oreal
17923448 EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME Final Rejection SHIN-ETSU CHEMICAL CO., LTD.
17769592 USE OF MBV FOR TREATING AUTOIMMUNE DISEASE Final Rejection University of Pittsburgh - Of the Commonwealth System of Higher Education
17625962 Herbicidal Mixtures Containing Amine Salts of Acidic Herbicides Final Rejection MONSANTO TECHNOLOGY LLC
18902135 POLYMER NANOPARTICLE COMPOSITIONS FOR NON-VIRAL GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM Non-Final OA BATTELLE MEMORIAL INSTITUTE
17949484 CURABLE COMPOUNDS AND FORMULATIONS FOR BIOMEDICAL APPLICATIONS Non-Final OA 3D SYSTEMS, INC.
18424973 SURFACE TREATMENT OF CONTACT LENS AND TREATMENT OF OCULAR DISCOMFORT BY WATER SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES Non-Final OA Yeda Research and Development Co. Ltd.
17573985 Dental Materials For The Production Of Temporary Crowns And Bridges Non-Final OA Ivoclar Vivadent AG
18591795 DUAL-TARGETING BIOMIMETIC LIPOSOME WITH ELEMENE (ELE) AND CABAZITAXEL (CTX), AND PREPARATION METHOD AND USE THEREOF Non-Final OA HANGZHOU NORMAL UNIVERSITY
17893273 BIOCOMPATIBLE STRUCTURE, AND FABRICATING METHODS AND APPLICATIONS OF SAME Non-Final OA BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
18659817 METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION Non-Final OA New York Blood Center, Inc.
18704916 USE OF MILK EXOSOME IN PREPARATION OF DRUG CARRIER Non-Final OA Panexo Biotech SG PTE. LTD
16857458 INTRACANALICULAR HYDROGEL INSERTS FOR THE DELIVERY OF ANESTHETICS Final Rejection Ocular Therapeutix, Inc.
17753795 STICKER FORMULATION CONTAINING A SULFOPOLYMER Non-Final OA Eastman Chemical Company
17926847 ANTIVIRAL POLYMERS Non-Final OA The University of Manchester
17619404 PLANT TREATMENT COMPOSITION Final Rejection Croda International Plc
18571238 LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME Non-Final OA THERNA THERAPEUTICS
18491871 MODIFIED RELEASE FORMULATIONS OF PRIDOPIDINE Non-Final OA Prilenia Neurotherapeutics Ltd.
17604587 PROCESS FOR CROSSLINKING A POLYMER Non-Final OA LABORATOIRES VIVACY
16069826 DEVICES AND COMPOSITIONS AND METHODS OF USE THEREOF Final Rejection RevBio, Inc.
17604439 Pharmaceutical Inhalation Aerosol and Preparation Method Therefor Final Rejection CF PharmTech, Inc.
17538714 MULTIFUNCTIONAL MICROCARRIERS WITH THERMO-RESPONSIVE BIOMATERIAL COATING AND USE THEREOF Final Rejection UVic Industry Partnerships Inc.
17497800 YARNS AND FIBERS OF POLY(BUTYLENE SUCCINATE) AND COPOLYMERS THEREOF, AND METHODS OF USE THEREOF Final Rejection Tepha, Inc.
17006705 MEDICAL DEVICES CONTAINING POLY(BUTYLENE SUCCINATE) AND COPOLYMERS THEREOF Non-Final OA Tepha, Inc.
17601325 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE Non-Final OA SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC,
17635815 DRUG-POLYMER AMORPHOUS SOLID DISPERSIONS USING LINEAR POLY(ACRYLIC ACID) POLYMERS Final Rejection LUBRIZOL ADVANCED MATERIALS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month